Noked Capital’s Zimmer Biomet ZBH Stock Holding History

Noked Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,369	Closed	-$344K	–	64
2019 Q4	$344K	Buy	+2,369	New	+$327K	0.39%	34

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Noked Capital's ZBH Position: Q1 2020 in Review

Noked Capital sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 2,369 shares — an estimated $344K sold.

Noked Capital first reported a position in ZBH in Q4 2019 and held it in 1 quarter. The position peaked at $344K in Q4 2019. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

Noked Capital reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
Noked Capital sold 2,369 Zimmer Biomet shares in Q1 2020, an estimated $344K.
Noked Capital first reported a position in Zimmer Biomet in Q4 2019 and held it in 1 quarter.
Noked Capital's Zimmer Biomet position peaked at $344K in Q4 2019.
883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on Noked Capital's 13F filing for Q1 2020, filed 26 May 2020.